Anti‐apoptotic signals of granulocyte‐macrophage colony‐stimulating factor are transduced via Jak2 tyrosine kinase in eosinophils

Cytokine‐mediated inhibition of eosinophil apoptosis is a mechanism causing tissue eosinophilia. Previously published work suggested that activation of the Lyn‐Ras‐Raf‐1‐MAP kinase pathway is obligatory for prevention of eosinophil apoptosis by eosinophil hematopoietins. We demonstrate herein that activation of freshly isolated human blood eosinophils by granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) is associated with increased tyrosine phosphorylation of Jak2. The tyrosine kinase blocker, tyrphostin B42, prevented activation of Jak2 but not Lyn, suggesting that Jak2 is the specific target for tyrphostin B42 in eosinophils. In addition, since Lyn remained unaffected by tyrphostin B42, it is unlikely that Jak2 is required for Lyn activation in this model. To test whether tyrosine phosphorylation of Jak2 is linked to GM‐CSF‐mediated prolonged eosinophil survival, we determined the effect of tyrphostin B42 on eosinophil viability and apoptosis. Prevention of Jak2 activation by tyrphostin B42 was associated with the inability of GM‐CSF to prevent eosinophil apoptosis. These data suggest that disruption of not only the Lyn‐Ras‐Raf‐1‐MAP kinase but also the Jak‐STAT pathway blocks the ability of eosinophil survival factors to prevent apoptosis in eosinophils.

[1]  J. O’Shea Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet? , 1997, Immunity.

[2]  C. Bachert,et al.  Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. , 1997, Journal of immunology.

[3]  E. W. Pearson,et al.  Critical role of Lyn kinase in inhibition of neutrophil apoptosis by granulocyte-macrophage colony-stimulating factor. , 1996, Journal of immunology.

[4]  G. Mills,et al.  Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils , 1996, The Journal of experimental medicine.

[5]  A. Levitzki,et al.  Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor , 1996, Nature.

[6]  W. Busse,et al.  IL-5 activates a 45-kilodalton mitogen-activated protein (MAP) kinase and Jak-2 tyrosine kinase in human eosinophils. , 1996, Journal of immunology.

[7]  J. Drazen,et al.  Sorting out the cytokines of asthma , 1996, The Journal of experimental medicine.

[8]  R. Alam,et al.  Mechanism of inhibition of eosinophil activation by transforming growth factor-beta. Inhibition of Lyn, MAP, Jak2 kinases and STAT1 nuclear factor. , 1995, Journal of immunology.

[9]  S. Stafford,et al.  The activation of the Jak-STAT 1 signaling pathway by IL-5 in eosinophils. , 1995, Journal of immunology.

[10]  R. Alam,et al.  The intracellular signal transduction mechanism of interleukin 5 in eosinophils: the involvement of lyn tyrosine kinase and the Ras-Raf-1- MEK-microtubule-associated protein kinase pathway , 1995, The Journal of experimental medicine.

[11]  P. Coffer,et al.  Interleukin-5 signaling in human eosinophils involves JAK2 tyrosine kinase and Stat1 alpha. , 1995, Blood.